NEWS & EVENTS
Company News
Press Release
For Immediate Release
June 19, 2008
Contact: Gregg DiPietro
Leerink Swann
(617) 918-4601
Gregg.DiPietro@leerink.com
Contact: Brian Bogie/Laura Coluci
Schwartz Communications
(781) 684-0770
Leerink@schwartz-pr.com
Leerink Swann Bolsters Investment Banking Team: Announces Key Hires in M&A and Corporate Finance
Boston, MA – June 19, 2008 - Healthcare investment bank Leerink Swann announced a significant expansion to its investment banking team with key additions to its Mergers and Acquisitions and Corporate Finance groups. Adam Berger and Daniel Lepanto have joined Leerink Swann’s Mergers and Acquisitions Group, and Marc Grasso, M.D. has joined the Corporate Finance Group.
Adam Berger joins Leerink Swann as a Managing Director and Head of Mergers and Acquisitions. Immediately prior to joining Leerink Swann, Mr. Berger was a Managing Director and Head of Healthcare Mergers and Acquisitions for Citigroup Global Markets, having been with the firm since 1991 when he joined Salomon Brothers. During his 19 year M&A career, Mr. Berger has advised on over 125 transactions totaling nearly $400 billion in value. He holds a B.S. and B.A from The Wharton School and the University of Pennsylvania, where he graduated Phi Beta Kappa and Magna Cum Laude.
Daniel Lepanto joins Leerink Swann as a Managing Director in the Mergers and Acquisitions Group. He joins from Cowen and Company, where he was most recently a Managing Director in their Mergers and Acquisitions group. During a ten year period at Cowen, Mr. Lepanto executed a wide range of mergers, acquisitions and other strategic advisory transactions, and provided primary advisory coverage for a number of core healthcare clients in biotechnology, medical technology and healthcare services. Prior to Cowen, Mr. Lepanto worked in Mergers and Acquisitions for UBS Securities and began his career in M&A with Wasserstein Perella. He holds a B.S. with high honors from Pennsylvania State University.
Dr. Marc Grasso joins Leerink Swann as a Managing Director and Head of West Coast Investment Banking from Morgan Stanley, where he was an Executive Director in the Healthcare Group. Over the past ten years, Dr. Grasso has focused on capital raising and strategic advisory services for leading biotechnology, pharmaceutical, and other healthcare companies. Prior to joining Morgan Stanley, Dr. Grasso was a Vice President in the Healthcare Group of Credit Suisse First Boston. He joined Credit Suisse from BT Alex. Brown, where he began his career in investment banking. Dr. Grasso received his Doctor of Medicine degree from Johns Hopkins School of Medicine and received his A.B. with Honors from Princeton University.
"Adam, Dan, and Marc represent outstanding additions to our Investment Banking team,” said David Ogens, Senior Managing Director and Head of Investment Banking. "Each has tremendous depth and a long history of success in their respective areas of expertise. All three will further enhance Leerink Swann’s ability to deliver the highest quality advisory services to our healthcare clients and to earn the role of trusted advisor to these management teams. These additions reflect and underscore the tremendous momentum our platform is experiencing in the healthcare marketplace.”
About Leerink Swann
Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory, and asset management services for institutional, life sciences, and high-net-worth clients. For the past seven years, Institutional Investor has named Leerink Swann Best of the Boutiques in several healthcare categories. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member of FINRA/SIPC.
- END -